Abstract:Cocrystallization of racemic-compound-forming chiral molecules can result in conglomerate cocrystals or diastereomerically related cocrystals, which enable the application of chiral separation techniques such as preferential crystallization and classic resolution. Here, a systematic method to identify the types and phase diagrams of cocrystals formed by chiral target compounds and candidate coformers in a particular solvent system is presented, which allows the design of suitable chiral resolution processes. The method is based on saturation temperature measurements of specific solution compositions containing both enantiomers of chiral molecules and a coformer. This method is applied to analyze three different systems. For racemic phenylalanine (Phe) in water/ethanol mixtures one of the enantiomers selectively cocrystallizes with the opposite enantiomer of valine (Val), forming the more stable diastereomerically related cocrystal. The racemic compound ibuprofen crystallizes with the nonchiral coformer 1,2-bis(4-pyridyl)ethane (BPN) as racemic compound cocrystals. More interestingly, when it is combined with <i>trans</i>-1-(2-pyridyl)-2-(4-pyridyl)ethylene (BPE), the racemic compound ibuprofen cocrystallizes as a conglomerate, which in principle enables the application of preferential crystallization of this racemic compound. The systematic method shows the benefit of using pseudo-binary phase diagrams. Such pseudo-binary phase diagrams depict the saturation temperature on a very specific route through the quaternary phase diagram, allowing the identification of various cocrystal types as well as the corresponding cocrystallization conditions. The systematic method can be used to identify a suitable solid phase for chiral separation, and the obtained phase diagram information enables the performance of a crystallization-mediated chiral resolution process design. Such a guideline for a chiral resolution process design has never been reported for conglomerate cocrystal systems such as IBU:BPE, presented in this study.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.cgd.0c00890?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.cgd.0c00890</a>.XRPD diffractograms of all relevant crystalline products from the present study (<a class="ext-link" href="/doi/suppl/10.1021/acs.cgd.0c00890/suppl_file/cg0c00890_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Bifunctional Chiral Agent Enables One‐pot Spontaneous Deracemization of Racemic Compounds

Deracemization of Atropisomeric Biaryls Enabled by Copper Catalysis

Enantioselective Cascade Biocatalysis for Deracemization of Racemic β‐Amino Alcohols to Enantiopure ( S )‐β‐Amino Alcohols by Employing Cyclohexylamine Oxidase and ω‐Transaminase

Deracemization of Racemic Amine Using ω-Transaminase and a Nickel-Based Nanocatalyst

Enantioseparation of 2-(Substituted Phenyl)propanoic Acids by High-Speed Countercurrent Chromatography and Investigation of the Influence of Substituents in Enantiorecognition.

Achiral Co‐Catalyst Induced Switches in Catalytic Asymmetric Reactions on Racemic Mixtures (RRM): from Stereodivergent RRM to Stereoconvergent Deracemization by Combination of Hydrogen Bond Donating and Chiral Amine Catalysts

Designing single chirality via crystallization method: spontaneous chiral symmetry breaking and deracemization

Deracemization of aryl secondary alcohols via enantioselective oxidation and stereoselective reduction with tandem whole-cell biocatalysts

Photoexcited Palladium-Catalyzed Deracemization of Allenes

Deracemization of racemic alcohols combining photooxidation and biocatalytic reduction.

Crystallization Resolution of Racemic Compounds Via Chiral Surfactant

Catalytic Deracemization Reactions

Case of Chiral Resolution through Converting Two Racemic Compounds into a Conglomerate

Deracemization Enabled by Visible-Light Photocatalysis.

Screening Approach for Identifying Cocrystal Types and Resolution Opportunities in Complex Chiral Multicomponent Systems

Multiplicative enhancement of stereoenrichment by a single catalyst for deracemization of alcohols

Kinetic Resolution of Racemic 4-Substituted Chroman-2-ones Through Asymmetric Lactone Hydrogenation

LC enantioseparation of active pharmaceutical ingredients using rationally synthesized CDRs and chiral molecules with high molar absorptivity

Deracemization through photochemical E / Z isomerization of enamines

Enantiodivergent Cyclization of Racemic Cyclohexadienones via Parallel Kinetic Asymmetric Transformation

Photochemical Deracemization of N‐Carboxyanhydrides en route to Chiral α‐Amino Acid Derivatives